| Literature DB >> 31221095 |
Xiuzhen Chen1, Junren Li1, Xiaobing Wang1, Liting Zhong1, Yun Tang1, Xuanxuan Zhou1, Yanting Liu1, Ruoting Zhan1, Hai Zheng2, Weiwen Chen1, Likai Chen3.
Abstract
BACKGROUND: Pogostemon cablin (Blanco) Benth. (Patchouli) is an important aromatic and medicinal plant and widely used in traditional Chinese medicine as well as in the perfume industry. Patchoulol is the primary bioactive component in P. cablin, its biosynthesis has attracted widespread interests. Previous studies have surveyed the putative genes involved in patchoulol biosynthesis using next-generation sequencing method; however, technical limitations generated by short-read sequencing restrict the yield of full-length genes. Additionally, little is known about the expression pattern of genes especially patchoulol biosynthesis related genes in response to methyl jasmonate (MeJA). Our understanding of patchoulol biosynthetic pathway still remained largely incomplete to date.Entities:
Keywords: Expression profile; Full-length transcriptome; MeJA; Patchoulol; Pogostemon cablin
Mesh:
Substances:
Year: 2019 PMID: 31221095 PMCID: PMC6585090 DOI: 10.1186/s12870-019-1884-x
Source DB: PubMed Journal: BMC Plant Biol ISSN: 1471-2229 Impact factor: 4.215
Investigation of the volatile chemical constituents in P. cablin leaves using GC-MS
| ID | Compound | CAS | Formula | Chloroform | Ethyl alcohol | Ethyl acetate | n-Hexane |
|---|---|---|---|---|---|---|---|
| 1 | 1,5-Cyclodecadiene, 1,5-dimethyl-8-(1-methylethenyl)-, [S-(Z,E)]- | 75,023–40-4 | C15H24 | ○ | |||
| 2 | β-Elemene | 515–13-9 | C15H24 | ○ | |||
| 3 | trans-Caryophyllene | 87–44-5 | C15H24 | ○ | ○ | ○ | ○ |
| 4 | β-Caryophyllene | 87–44-5 | C15H24 | ○ | ○ | ||
| 5 | α-Guaiene | 3691-12-1 | C15H24 | ○ | ○ | ○ | ○ |
| 6 | Seychellene | 20,085–93-2 | C15H24 | ○ | ○ | ○ | ○ |
| 7 | 1H-3a,7-Methanoazulene, 2,3,6,7,8,8a-hexahydro-1,4,9,9-tetramethyl-, (1.alpha.,3a.alpha.,7.alpha.,8a.beta.)- | 560–32-7 | C15H24 | ○ | ○ | ○ | ○ |
| 8 | α-Gurjunene | 489–40-7 | C15H24 | ○ | ○ | ○ | |
| 9 | α-Muurolene | 31,983–22-9 | C15H24 | ○ | |||
| 10 | Azulene, 1,2,3,3a,4,5,6,7-octahydro-1,4-dimethyl-7-(1-methylethenyl)-, [1R-(1.alpha.,3a.beta.,4.alpha.,7.beta.)]- | 22,567–17-5 | C15H24 | ○ | ○ | ||
| 11 | Aciphyllene | 87,745–31-1 | C15H24 | ○ | ○ | ○ | |
| 12 | Azulene, 1,2,3,5,6,7,8,8a-octahydro-1,4-dimethyl-7-(1-methylethenyl)-, [1S-(1.alpha.,7.alpha.,8a.beta.)]- | 3691-11-0 | C15H24 | ○ | ○ | ○ | ○ |
| 13 | Alloaromadendrene | 25,246–27-9 | C15H24 | ○ | |||
| 14 | (1R,4aS,6R,8aS)-8a,9,9-Trimethyl-1,2,4a,5,6,7,8,8a-octahydro-1,6-methanonaphthalen-1-ol | 41,429–52-1 | C15H22O | ○ | ○ | ||
| 15 | (1S,1aS,1bR,4S,5S,5aS,6aR)-1a,1b,4,5a-Tetramethyldecahydro-1,5-methanocyclopropa [a]indene | 52,617–34-2 | C15H24 | ○ | |||
| 16 | (+) spathulenol | 77,171–55-2 | C15H24O | ○ | ○ | ||
| 17 | Isoaromadendrene epoxide | 1,000,159–36-6 | C15H24O | ○ | |||
| 18 | cis-Z-α-Bisabolene epoxide | 1,000,131–71-2 | C15H24O | ○ | ○ | ||
| 19 | 1,4-Dimethyl-7-(prop-1-en-2-yl)decahydroazulen-4-ol | 21,698–41-9 | C15H26O | ○ | |||
| 20 | Patchouli alcohol | 5986-55-0 | C15H26O | ○ | ○ | ○ | ○ |
| 21 | 4,7-Methanoazulene, 1,2,3,4,5,6,7,8-octahydro-1,4,9,9-tetramethyl-, [1S-(1.alpha.,4.alpha.,7.alpha.)]- | 514–51-2 | C15H24 | ○ | ○ | ○ | |
| 22 | 4-Hydroxy-6-methyl-3-(4-methylpentanoyl)-2H-pyran-2-one | 23,800–56-8 | C12H16O4 | ○ | |||
| 23 | 2H-Cyclopropa [g] benzofuran, 4,5,5a,6,6a,6b-hexahydro-4,4,6b-trimethyl-2-(1-methylethenyl)- | 102,681–49-2 | C15H22O | ○ | |||
| 24 | (1R,4S,5S)-1,8-Dimethyl-4-(prop-1-en-2-yl)spiro[4.5]dec-7-ene | 43,219–80-3 | C15H24 | ○ | ○ | ||
| 25 | Caryophyllene oxide | 1139-30-6 | C15H24O | ○ | |||
| 26 | 1,4-Methanocycloocta [d] pyridazine, 1,4,4a,5,6,9,10,10a-octahydro-11,11-dimethyl-, (1.alpha.,4.alpha.,4a.alpha.,10a.alpha.)- | 1,000,221–85-9 | C13H20N2 | ○ | |||
| 27 | d-Nerolidol | 142–50-7 | C15H26O | ○ | |||
| 28 | Farnesol | 4602-84-0 | C15H26O | ○ | ○ | ||
| 29 | (+)-Aromadendrene | 489–39-4 | C15H24 | ○ | ○ | ||
| 30 | 1,11-Hexadecadiyne | 71,673–32-0 | C16H26 | ○ | |||
| 31 | 2,6,11,15-Tetramethyl-hexadeca-2,6,8,10,14-pentaene | 38,259–79-9 | C20H32 | ○ | ○ | ||
| 32 | 1,2-Benzenedicarboxylic acid, bis(2-methylpropyl) ester | 84–69-5 | C16H22O4 | ○ | |||
| 33 | 1,2-Benzenedicarboxylic acid, dibutyl ester | 84–74-2 | C16H22O4 | ○ | ○ | ||
| 34 | 2-(3,4-Dimethyloxyphenyl)-2,3-dihydro-5,7-dihydroxy-4H-1-benzopyran-4-one | 1,000,395–79-6 | C17H16O6 | ○ | |||
| 35 | Squalene | 111–02-4 | C30H50 | ○ | ○ | ○ | ○ |
| 36 | Vitamin E | 59–02-9 | C29H50O2 | ○ | |||
| 37 | Oxiraneoctanoic acid, 3-octyl-, methylester | 2500-59-6 | C19H36O3 | ○ | |||
| 38 | γ-Sitosterol | 83–47-6 | C29H50O | ○ | |||
| 39 | Bis(2-ethylhexyl) phthalate | 117–81-7 | C24H38O4 | ○ | ○ |
Fig. 1PacBio single-molecule long-read sequencing of P. cablin. a Summary of reads from PacBio Iso-Seq. b Comparison of quality from cluster consensus transcripts and corrected transcripts. c Length distribution of Iso-Seq consensus Transcripts and full-length UniTransModels. d Length distribution of CDS
Summary of functional annotation results for P.cablin. UniTransModels to public databases
| Annotated databases | Nr | SwissProt | KEGG | KOG | GO | Nt | Pfam | Total |
|---|---|---|---|---|---|---|---|---|
| Transcript Number | 59,188 | 53,172 | 57,164 | 33,793 | 15,036 | 46,110 | 15,036 | 65,826 |
| Percentage (%) | 71.89 | 64.58 | 69.43 | 41.04 | 18.26 | 56 | 18.26 | 79.95 |
Fig. 2Functional annotation and classification of P. cablin UniTransModels. a GO classification of P. cablin UniTransModels. b KOG functional classification of P. cablin UniTransModels. c KEGG pathway classification of P. cablin UniTransModels
Number of annotated CDS of P. cablin. in UniProtKB
| Number of CDS | Percentage (%) | |
|---|---|---|
| UniPortKB_ | 23,717 | 73.58 |
| UniProtKB_ | 21,778 | 67.57 |
| UniProtKB | 21,166 | 65.67 |
| Total | 23,754 | 73.7 |
Fig. 3Identification of lncRNAs and Transcription Factors (TFs) in P. cablin transcriptome. a Venn diagram of the number lncRNAs predicted by CPC, CNCI and Pfam protein structure analysis. b Length distribution of lncRNAs of P. cablin. c Comparison of the primary transcription factor families identified in P. cablin transcriptome to which in Arabidopsis thaliana and Oryza sativa
Fig. 4Patchoulol content and genes expression pattern in patchouli leaves induced by MeJA. a GC-MS chromatogram of leaves extracts from plant sprayed with or without MeJA. b Contents of patchoulol in leaves significantly increased after MeJA treatment. The amount of patchoulol was first calculated comparing with external standard and then dividing by the fresh weight of the samples. Error bars indicate the SD of three biological replicates. ** indicates significant difference of the means at p < 0.01 between non-treantment (CK) and MeJA-treatment leaves for each parameter mesureed (n = 3). c Abundance of DEGs in leaf tissues in response to MeJA treatment. The heat map showing genes having a fold change ratio ≥ 2, with corrected p-value<0.01. d Abundance changes of transcripts involved in the cytosolic MVA, plastidial MEP, and P. cablin patchoulol biosynthesis pathways in response to MeJA. The expressions are indicated by heat map, estimated using Log2(foldchange) value for each transcript. Magenta means high expression and green means low expression, the color gradually from green to magenta represents gene expression abundance from low to high
Fig. 5Expression profiles of genes associated with JA synthesis and signaling in patchouli induced by MeJA (foldchange > 1.5. p-value ≤0.05). a Heat map depicting abundance change of JAZ- and JAR1 co-orthologues. Blue color in the map represents low transcript abundance and red represents high level of transcript abundance. The same below. b Heat map depicting differential expression pattern of transcription factors in P. cablin induced by MeJA
Fig. 6Validation of expression patterns of JAZ proteins and ERFs by qRT-PCR. The relative expression levels were calculated according to the 2-ΔΔCT method using Pat18S as internal reference gene. Error bars represent standard deviations. * indicates significant difference of the means at p < 0.05 between non-treantment (CK) and MeJA-treatment leaves for each parameter mesureed (n = 3). The relative expression of qRT-PCR is indicated on the left y-axis and the normalized expression level (FPKM) of RNA sequencing is indicated on the right y-axis